ArticleBMC cardiovascular disorders2026
The association of the serum free triiodothyronine to free thyroxine ratio with contrast-induced nephropathy and long-term outcomes in elective percutaneous coronary intervention: a retrospective study.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThis study was designed to investigate the impact of the serum free triiodothyronine to free thyroxine ratio (FT3/FT4) on both the incidence and long-term prognosis of contrast-induced nephropathy (CIN) following elective percutaneous coronary intervention (PCI).
methodsThis retrospective study was conducted among patients who underwent elective PCI at the Second Hospital of Tianjin Medical University from January 1, 2019, to March 31, 2022. The diagnosis of CIN was established when serum creatinine (SCr) level increased by more than 44.2 mol/L (0.5 mg/dL) or 25% compared to baseline within 48-72 h post-PCI. Logistic regression analysis was employed to identify independent predictors of CIN. Cox regression and survival analysis were utilized to assess factors influencing all-cause and cardiovascular mortality. Furthermore, the correlation between FT3/FT4 and the occurrence of CIN was examined via restricted cubic spline (RCS) analysis.
resultsThe study encompassed a cohort of 1,390 patients, out of whom 173 (12.4%) experienced CINs. Patients diagnosed with CIN exhibited advanced age, a greater prevalence of acute myocardial infarction (AMI) and chronic renal dysfunction, along with a lower level of FT3/FT4 (all P < 0.001). Stratification based on FT3/FT4 quartile resulted in four distinct patient groups. Notably, significant distinctions emerged among the groups in terms of CIN occurrence, all-cause mortality, cardiovascular mortality. RCS analysis depicted a J-shaped relationship between FT3/FT4 levels and the incidence of CIN. The curve showed an inflection point at an FT3/FT4 ratio of approximately 0.306. CIN risk initially decreases and then increases with the increase of FT3/FT4 ratio. Several factors were identified as risk factors for all-cause mortality, including age, myocardial infarction, LVEDD, SCr before PCI, diuretic usage, left main coronary artery disease, and left circumflex artery disease. Conversely, diastolic blood pressure, serum albumin, post ballooning, statin usage, and FT3/FT4 demonstrated protective effects.
conclusionThe FT3/FT4 level was significantly associated with both incidence of CIN and long-term all-cause mortality in patients undergoing elective PCI.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.